When to Seek Medical Guidance About Digestive Issues on Semaglutide Contact your healthcare provider if you experience severe constipation, abdominal pain, bloating that doesn't improve with simple measures, or signs of dehydration (dark urine, dizziness, extreme thirst)
"FDA approves Novo Nordisk's oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event" (Press release)
Semaglutide 2.4 mg, a glucagon-like peptide-1 receptor agonist, is a once-weekly injectable pharmacological treatment, indicated in combination with diet and exercise, for reducing body weight in adults with obesity or overweight and at least one ORC [8]
See full important safety information below
CircRNA-COL1A2 promotes pyroptosis and oxidative stress in HG-treated TECs by regulating the miR-424-5p/SGK1 pathway (183)
2.11 Recommended Dosage for Allergic Fungal Rhinosinusitis 2.12 Missed Doses If a weekly dose is missed, administer the dose as soon as possible, and start a new weekly schedule from the date of the last administered dose